norwalklik
virus
nlv
genet
divers
group
human
calicivirus
common
caus
epidem
gastroenter
detect
typic
stool
revers
transcript
rt
pcr
electron
microscopi
em
applic
rapid
nucleic
acid
sequencebas
amplif
nasba
assay
detect
nlv
rna
stool
describ
use
nuclisen
basic
kit
primer
probe
nlv
basic
kit
assay
base
rna
polymeras
region
prototyp
nlv
norwalk
viru
nv
genom
could
consist
detect
rtpcr
detect
unit
nv
rna
stool
filtrat
compar
directli
rtpcr
dilut
seri
nv
stool
filtrat
nuclisen
basic
kit
assay
equal
sensit
crossreact
studi
repres
panel
enter
pathogen
neg
appli
stool
specimen
nvchalleng
volunt
nasba
basic
kit
applic
nv
detect
yield
sensit
specif
concord
use
rtpcr
gold
standard
despit
specif
nasba
primerprob
sequenc
nv
repres
nlv
genogroup
ii
could
detect
basic
kit
assay
outbreak
stool
specimen
although
result
inconsist
result
suggest
nuclisen
basic
kit
assay
provid
rapid
sensit
altern
rtpcr
detect
nv
rna
stool
specimen
howev
improv
test
specif
primer
design
need
assay
use
routin
clinic
set
norwalklik
virus
nlv
also
call
norovirus
genet
divers
genu
classifi
famili
calicivirida
green
et
al
virus
contain
positivesens
singl
strand
rna
genom
approxim
kb
base
sequenc
inform
gene
encod
viral
rnadepend
rna
polymeras
capsid
protein
nlv
genu
subdivid
two
genogroup
genogroup
norwalk
viru
nv
prototyp
strain
genogroup
ii
snow
mountain
hawaii
viru
prototyp
strain
nlv
implic
outbreak
acut
nonbacteri
gastroenter
us
document
center
diseas
control
prevent
cdc
fankhaus
et
al
addit
nlv
major
caus
acut
nonbacteri
gastroenter
children
adult
worldwid
bon
et
al
park
et
al
taylor
et
al
vinj
et
al
nlv
outbreak
report
commun
school
day
care
center
nurs
home
hospit
recreat
area
cruis
ship
militari
ship
base
fankhaus
et
al
grohmann
et
al
mccarthi
et
al
sharp
et
al
virus
replic
gastrointestin
tract
infect
host
excret
fece
although
foodborn
transmiss
common
virus
also
transmit
fecal
contamin
drink
recreat
water
well
contact
contamin
environment
surfac
infect
individu
despit
numer
attempt
nlv
infect
induc
experiment
anim
virus
propag
success
cell
cultur
diagnosi
reli
histor
observ
nm
viral
particl
electron
microscopi
em
glass
et
al
howev
nlv
shed
usual
low
concentr
em
frequent
sensit
enough
detect
virus
stool
earli
diagnost
test
nv
develop
primarili
immunoassay
requir
reagent
deriv
nvinfect
human
volunt
wide
avail
atmar
est
clone
sequenc
nv
jiang
et
al
led
develop
new
molecular
diagnost
assay
current
detect
method
use
wide
nlv
stool
sampl
revers
transcript
rt
pcr
result
rtpcr
amplicon
confirm
probe
hybrid
nucleotid
sequenc
analysi
rtpcr
proven
extrem
sensit
method
detect
nlv
howev
method
sever
drawback
presenc
amplif
inhibitor
stool
sampl
need
confirm
amplif
product
prevent
fals
posit
result
amount
time
need
complet
analysi
rapid
identif
pathogen
import
patient
care
prompt
appropri
intervent
control
outbreak
diseas
studi
demonstr
isotherm
nucleic
acid
sequencebas
amplif
nasba
method
provid
sensit
rapid
method
detect
viral
rna
human
immunodefici
viru
type
berndt
et
al
fiscu
et
al
segondi
et
al
van
gemen
et
al
epsteinbarr
viru
ebv
brink
et
al
cruz
et
al
human
cytomegaloviru
hcmv
blok
et
al
witt
et
al
human
rhinoviru
enteroviru
damen
et
al
lunel
et
al
rna
amplif
method
util
three
enzym
revers
transcriptas
rna
polymeras
rnaseh
two
target
specif
oligonucleotid
primer
revers
oligonucleotid
primer
contain
bacteriophag
promot
sequenc
forward
oligonucleotid
primer
contain
electrochemiluminesc
ecl
tail
use
detect
amplif
product
transcriptiondriven
nasba
reaction
amplifi
theoret
rna
target
fold
within
min
studi
report
applic
rapid
nasba
assay
detect
nv
rna
stool
use
nuclisen
basic
kit
assay
compar
directli
rtpcr
use
detect
nv
nlv
fecal
specimen
obtain
human
challeng
studi
nlv
outbreak
nasba
assay
describ
optim
detect
nv
nasba
primer
probe
design
reactiv
broadli
nlv
nv
stock
prepar
use
studi
made
suspens
pb
liquid
stool
volunt
infect
nv
inoculum
dolin
et
al
stool
suspens
trichlorotrifluoroethan
freon
extract
three
time
filter
mm
filter
first
second
filtrat
pool
aliquot
ml
portion
store
viru
concentr
estim
endpoint
titrat
rtpcr
use
heat
releas
method
schwab
et
al
oligonucleotid
primer
base
sequenc
nv
polymeras
gene
moe
et
al
estim
nv
concentr
stock
prepar
rang
pcr
detect
unit
pdu
per
ml
mean
pduml
polioviru
type
strain
lsc
propag
bgmk
african
greenmonkey
kidney
deriv
cell
titer
use
plaqu
techniqu
sobsey
hepat
viru
hav
cytopath
strain
grown
plaqu
assay
enumer
use
fetal
rhesu
monkey
kidneyderiv
cell
cromean
et
al
virus
test
panel
includ
adenoviru
astroviru
human
rotaviru
gift
mark
sobsey
depart
environment
scienc
engin
uncch
coronaviru
gift
ralph
baric
depart
epidemiolog
uncch
gram
neg
bacteri
strain
includ
escherichia
coli
atcc
e
coli
hc
cultiv
overnight
brain
heart
infus
bhi
broth
difco
detroit
mi
clostridium
perfringen
nctc
cultiv
fluid
thioglycol
ftg
medium
difco
h
aliquot
stool
specimen
collect
nv
human
challeng
studi
moe
et
al
prepar
suspens
steril
water
store
prior
use
fecal
specimen
collect
sever
nlv
outbreak
prepar
similar
manner
viral
rna
isol
nv
stock
prepar
stool
specimen
viral
rna
isol
rtpcr
assay
stool
specimen
nv
human
challeng
studi
nlv
outbreak
test
rtpcr
use
modifi
heat
releas
method
schwab
et
al
biotecx
houston
tx
rna
extract
method
accord
manufactur
direct
nv
stock
prepar
contain
pduml
serial
dilut
nuclisen
basic
kit
lysi
buffer
inc
durham
nc
rna
extract
per
manufactur
instruct
extract
method
base
boom
et
al
briefli
nv
stocklysi
buffer
mixtur
mix
activ
silica
bound
viral
nucleic
acid
wash
ml
wash
buffer
guscu
tri
ph
twice
ml
ethanol
ml
aceton
wash
step
suspens
briefli
centrifug
silica
pellet
suspend
next
wash
solut
follow
dri
step
min
rna
elut
silica
incub
ml
nuclisen
basic
kit
elut
buffer
min
purifi
rna
store
prior
use
amplif
reaction
outbreak
challeng
studi
stool
specimen
stool
suspens
rather
prepar
steril
nucleasefre
water
sampl
pretreat
remov
inhibitor
centrifug
g
min
addit
ethanol
wash
incorpor
buffer
wash
step
facilit
remov
residu
amplif
inhibitor
rtpcr
dilut
seri
nv
stock
prepar
carri
use
ml
purifi
viral
rna
oligonucleotid
primer
pair
produc
amplicon
correspond
nucleotid
within
rna
polymeras
gene
nv
moe
et
al
reaction
carri
rtpcr
access
system
kit
promega
corpor
madison
wi
accord
manufactur
protocol
previous
report
moe
et
al
stool
specimen
human
challeng
studi
nlv
outbreak
test
rtpcr
use
primer
produc
product
nucleotid
also
within
rna
polymeras
gene
ando
et
al
primer
broadli
reactiv
pair
routin
use
screen
volunt
outbreak
specimen
presenc
nlv
infect
oligonucleotid
primer
prepar
patholog
oligonucleotid
facil
univers
north
carolina
chapel
hill
briefli
rt
done
min
heat
inactiv
revers
transcriptas
min
sampl
subject
cycl
min
min
min
follow
final
extens
min
result
dna
amplicon
electrophores
agaros
gel
stain
ethidium
bromid
electrophores
rtpcr
amplicon
transfer
hybondn
pharmacia
amersham
biotech
piscastaway
nj
hybrid
perform
label
oligo
label
detect
kit
pharmacia
amersham
biotech
use
nvint
oligonucleotid
probe
rtpcr
amplicon
sequenc
describ
previous
moe
et
al
primer
probe
sequenc
list
tabl
nasba
oligonucleotid
primer
bkp
correspond
pair
amplifi
bp
region
nv
rna
polymeras
gene
access
number
primer
design
label
rna
polymeras
promot
ecl
detect
sequenc
respect
cooper
tabl
nasba
reaction
use
ml
purifi
viral
rna
mm
primer
concentr
mm
kcl
reaction
perform
accord
nuclisen
basic
kit
instruct
briefli
ml
premix
cocktail
dispens
thinwal
eppendorf
tube
ml
nucleic
acid
eluat
ad
tube
tube
incub
min
follow
cool
min
aliquot
enzym
mix
rna
polymeras
rnase
h
amvrevers
transcriptas
ad
tube
follow
incub
min
water
bath
thermocycl
ecl
detect
done
immedi
amplif
altern
amplifi
rna
store
day
prior
ecl
detect
nasbagener
product
detect
liquid
hybrid
use
electrochemiluminesc
ecl
principl
employ
nuclisen
reader
method
use
two
oligonucleotid
ie
specif
captur
oligonucleotid
immobil
onto
paramagnet
bead
ii
second
detector
oligonucleotid
complex
ruthenium
chelat
specif
captur
probe
use
assay
correspond
nvint
probe
use
rtpcr
hybrid
except
biotinyl
manufactur
facilit
complex
streptavidinco
magnet
bead
detector
probe
sequenc
gener
provid
nuclisen
basic
kit
complementari
termin
end
amplicon
transcrib
stretch
nucleotid
identifi
primer
bkp
see
tabl
amplif
product
ml
dilut
ml
detect
buffer
provid
nuclisen
basic
kit
hybrid
carri
use
ml
mixtur
streptavidinco
captur
probe
coupl
magnet
bead
ru
oligonucleotid
detect
probe
ml
dilut
amplif
product
solut
incub
min
assay
buffer
ml
ad
tube
follow
detect
use
nuclisen
ecl
reader
incub
paramagnet
bead
carri
hybrid
ampliconecl
probe
complex
magnet
captur
surfac
electrod
part
ecl
reader
voltag
appli
electrod
trigger
ecl
reaction
light
emit
hybrid
ru
label
probe
proport
quantiti
amplicon
present
ecl
reader
detect
luminesc
energi
convert
digit
readout
reader
assign
specimen
posit
neg
outcom
base
luminesc
signal
specimen
rel
posit
neg
sampl
control
perform
control
provid
manufactur
ecl
result
transform
log
valu
subsequ
analys
use
microsoft
excel
redmond
citi
wa
rtpcr
done
use
ml
nasba
gener
amplif
product
oligonucleotid
primer
pair
moe
et
al
reaction
perform
describ
result
dna
amplicon
electrophores
agaros
gel
visual
ethidium
bromid
sequenc
analysi
result
bp
rtpcr
product
purifi
qiagen
pcr
qiagen
valencia
ca
nucleotid
sequenc
determin
univers
north
carolina
chapel
hill
autom
sequenc
facil
use
primer
nucleotid
sequenc
analys
done
use
wisconsin
genet
comput
group
gcg
softwar
basic
local
align
search
tool
blast
analysi
altschul
et
al
evalu
limit
detect
reproduc
basic
kit
assay
detect
nv
rna
serial
dilut
made
nv
stock
prepar
correspond
pduml
entir
basic
kit
method
appli
rna
isol
nasba
amplif
ecl
detect
dilut
test
triplic
three
differ
day
result
nine
replic
test
per
dilut
consist
detect
nv
rna
possibl
dilut
correspond
pduml
small
rel
standard
deviat
concentr
nv
reduc
equival
pduml
nasba
detect
slightli
less
consist
eight
nine
reaction
give
posit
amplif
result
dilut
larger
standard
deviat
observ
instanc
one
three
sampl
run
neg
viral
rna
detect
endpoint
occur
approxim
pduml
level
pduml
nasba
result
consist
neg
small
standard
deviat
result
summar
fig
show
fairli
reliabl
uppercas
letter
design
genom
sequenc
use
amplif
hybrid
design
lowercas
letter
indic
promot
sequenc
bkp
sequenc
specif
nuclisen
rutheniumlink
oligonucleotid
detector
probe
b
nvint
biotinyl
manufactur
facilit
bind
streptavidinlabel
magnet
sphere
captur
specif
amplicon
subsequ
detect
use
nuclisen
ecl
detect
modul
detect
nv
rna
nuclisen
basic
kit
assay
level
pduml
seriallydilut
stool
suspens
rna
prepar
test
rtpcr
use
primer
set
follow
southern
hybrid
observ
nasba
amplif
method
provid
sensit
detect
limit
furthermor
nuclisen
basic
kit
assay
complet
h
compar
h
rtpcr
southern
hybrid
ascertain
whether
bkp
amplif
primer
nvint
probe
specif
nv
amplif
detect
primerprob
combin
evalu
panel
repres
bacteri
viral
enter
pathogen
tabl
ecl
detect
neg
entir
panel
mean
log
ecl
signal
compar
mean
log
ecl
valu
nvposit
specimen
compar
clinic
sensit
nuclisen
basic
kit
assay
rtpcr
detect
nv
rna
stool
specimen
stool
specimen
infect
uninfect
volunt
nv
challeng
studi
collect
prechalleng
variou
time
postchalleng
test
rtpcr
nasba
tabl
nv
infect
volunt
also
confirm
elisa
igg
seroconvers
describ
previous
moe
et
al
five
specimen
posit
rtpcr
confirm
posit
ecl
signal
yield
test
sensit
use
rtpcr
gold
standard
log
posit
ecl
valu
rang
geometr
mean
five
specimen
neg
rtpcr
also
confirm
neg
nuclisen
basic
kit
assay
howev
two
volunt
sampl
vt
vt
neg
rtpcr
gave
inconsist
posit
result
use
nuclisen
basic
kit
specimen
test
neg
one
assay
posit
anoth
consid
true
fals
posit
obtain
subject
prior
nv
challeng
also
three
rtpcr
neg
sampl
gave
consist
posit
result
nasbaecl
log
ecl
signal
sampl
rang
geometr
mean
one
log
lower
geometr
mean
rtpcr
positivenuclisen
basic
kit
posit
sampl
sequenc
analysi
nasba
amplicon
obtain
three
sampl
confirm
pre
senc
target
nv
rna
two
three
specimen
vt
collect
nvinfect
volunt
later
postchalleng
time
day
postchalleng
rtpcr
posit
specimen
volunt
day
postchalleng
detect
nvposit
specimen
day
postchalleng
rtpcr
two
infect
volunt
data
shown
indic
viral
shed
possibl
time
period
howev
specimen
test
nuclisen
basic
kit
nasba
result
vt
vt
suggest
nuclisen
basic
kit
may
sensit
rtpcr
assay
howev
statement
made
cautious
third
rtpcr
neg
specimen
vt
day
postchalleng
posit
nuclisen
basic
kit
assay
volunt
indic
viral
shed
rtpcr
seroconvert
overal
specif
use
rtpcr
gold
standard
concord
rtpcr
nasba
result
compar
specif
nuclisen
basic
kit
nasba
method
rtpcr
outbreak
stool
specimen
examin
abil
basic
kit
assay
detect
nlv
use
oligonucleotid
primerprob
set
base
nv
genom
six
rtpcr
posit
stool
specimen
cdc
gi
gi
gi
gii
gii
toronto
gii
nlv
outbreak
test
use
nuclisen
basic
kit
assay
describ
one
three
genogroup
outbreak
strain
cdc
nucleotid
homolog
nv
posit
nasbaecl
assay
although
degre
posit
low
consist
run
run
two
strain
homolog
nv
neg
genogroup
ii
outbreak
strain
toronto
homolog
nv
toronto
strain
test
posit
use
nuclisen
basic
kit
assay
nvbase
primer
detect
probe
develop
studi
howev
seen
gi
strain
cdc
degre
posit
low
consist
run
run
two
gii
strain
consist
neg
data
shown
studi
report
applic
nucleic
acid
sequenc
base
amplif
assay
nasba
detect
nlv
prototyp
nv
strain
use
nuclisen
basic
kit
nuclisen
basic
kit
assay
compar
favor
parallel
rtpcr
assay
respect
assay
detect
limit
howev
nuclisen
basic
kit
assay
provid
rapid
altern
rtpcr
complet
h
former
compar
h
latter
furthermor
kit
format
boom
et
al
rna
extract
method
provid
eas
standard
less
experienc
laboratori
personnel
isotherm
amplif
approach
use
basic
kit
also
simplifi
equip
need
cost
compar
use
thermocycl
devic
tabl
compar
sensit
nuclisen
basic
kit
assay
rtpcr
detect
nv
rna
repres
stool
specimen
collect
nvchalleng
volunt
short
nuclisen
basic
kit
provid
promis
nucleic
acid
amplif
altern
combin
amplif
detect
confirm
simplifi
streamlin
protocol
nasba
proven
sensit
specif
assay
use
clinic
diagnost
microbiolog
commerci
kit
avail
detect
human
hiv
ebv
cmv
blood
plasma
mani
quantit
assay
investig
report
particularli
good
success
use
nasba
method
quantit
hiv
load
blood
plasma
berndt
et
al
dyer
et
al
recent
technolog
develop
detect
quantif
hcv
damen
et
al
candida
speci
widjojoatmodjo
et
al
parasit
plasmodium
falciparum
schoon
et
al
bloodbas
specimen
rna
sequenc
chlamydia
trachomati
deriv
urin
cervic
scrape
morr
et
al
well
rhinoviru
nasopharang
aspir
samuelson
et
al
also
detect
use
nasba
approach
knowledg
first
publish
report
use
nasba
technolog
detect
enter
pathogen
fecal
matrix
overal
nuclisen
basic
kit
method
rna
extract
result
highqual
rna
extract
capabl
support
nasba
amplif
sampl
dilut
level
infecti
viru
patient
acut
phase
viral
gastroenter
approach
g
fece
kapikian
et
al
potenti
method
routin
diagnosi
nv
infect
excel
rtpcr
assay
identif
broadli
reactiv
primer
detect
human
calicivirus
remain
challeng
primer
probe
set
use
studi
intend
demonstr
feasibl
nasba
amplif
detect
norwalk
viru
stool
therefor
design
specif
nv
strain
although
readili
abl
detect
prototyp
norwalk
viru
strain
primer
rel
ineffect
detect
genogroup
ii
nlv
strain
collect
foodborn
diseas
outbreak
even
though
result
anticip
find
support
need
broadli
reactiv
primer
improv
nucleic
acid
amplif
assay
design
detect
genet
divers
group
viral
pathogen
differ
rna
extract
method
use
nasba
assay
rtpcr
assay
nasba
assay
nuclisen
basic
kit
rna
extract
method
base
method
boom
et
al
use
per
manufactur
instruct
rtpcr
assay
use
two
method
work
well
experi
heat
releas
method
method
differ
method
may
explain
part
discrep
result
two
assay
specimen
well
known
sensit
specif
nucleic
acid
amplif
method
affect
effici
rna
isol
method
instanc
brink
et
al
brink
et
al
note
rel
sensit
nasba
detect
ebv
like
influenc
rna
isol
effici
amplif
effici
other
shown
effect
matrixassoci
inhibitor
amplif
effici
exacerb
low
level
target
templat
yield
fals
neg
fals
posit
result
jayku
et
al
loss
rna
extract
may
well
account
slightli
poorer
detect
limit
note
rtpcr
nuclisen
basic
kit
method
describ
paper
fig
compar
rtpcr
detect
limit
observ
dilut
norwalk
viru
stock
prepar
norwalk
viru
stock
solut
use
studi
titer
use
heatreleas
rtpcr
method
schwab
et
al
rather
boom
et
al
silicabas
method
follow
rtpcr
rel
high
degre
fals
posit
amplif
result
note
basic
kit
assay
may
also
associ
residu
matrix
compon
serv
templat
nonspecif
amplif
hybrid
may
possibl
improv
sensit
specif
amplif
use
altern
rna
extract
method
follow
amplif
detect
use
latter
two
step
nuclisen
basic
kit
approach
could
facilit
remov
residu
matrix
associ
compon
therebi
improv
effici
specif
subsequ
rna
amplif
studi
demonstr
use
nuclisen
basic
kit
applic
nasbaecl
method
rapid
sensit
detect
nv
rna
fecal
sampl
knowledg
first
studi
sought
appli
nasbaecl
amplif
detect
technolog
group
nlv
furthermor
viru
stock
use
experi
titer
previous
heatreleas
rtpcr
multipl
time
abl
establish
approxim
level
detect
appli
combin
rna
extract
nasba
amplif
ecl
detect
nuclisen
basic
kit
detect
limit
approxim
pdu
per
amplif
reaction
close
detect
limit
obtain
rtpcr
howev
eas
use
speed
detect
suppli
nuclisen
system
provid
signific
advantag
rtpcr
detect
approach
develop
optim
particularli
respect
primer
design
assay
specif
confid
nasba
ecl
technolog
continu
develop
viabl
method
detect
enter
pathogen
fecal
matric
